Filmed at EuroPCR 2022, Prof Stephan Baldus (University of Köln Medical Center, DE) outlines the first results from a study investigating the use of the JenaValve TAVR device in treating patients with aortic regurgitation.
1. Prevalence and burden of aortic regurgitation
2. Treatment options
3. Importance of the technology
4. Considerations and further research
Recorded at EuroPCR 22, Paris.
Interviewer: Jonathan McKenna
Videographer: Oliver Miles
Editor: Jordan Rance